| Literature DB >> 23936440 |
Verônica Torres Costa e Silva1, Fernando Liaño, Alfonso Muriel, Rafael Díez, Isac de Castro, Luis Yu.
Abstract
BACKGROUND: Delayed nephrology consultation (NC) seems to be associated with worse prognosis in critically ill acute kidney injury (AKI) patients. DESIGN SETTING PARTICIPANTS & MEASUREMENTS: The aims of this study were to analyze factors related with timing of NC and its relation with AKI patients' outcome in intensive care units of a tertiary hospital. AKI was defined as an increase ≥50% in baseline serum creatinine (SCr). Early NC and delayed NC were defined as NC performed before and two days after AKI diagnosis day. Multivariable logistic regression and propensity scores (PS) were used to adjust for confounding and selection biases. Hospital mortality and dialysis dependence on hospital discharge were the primary outcomes.Entities:
Mesh:
Year: 2013 PMID: 23936440 PMCID: PMC3732261 DOI: 10.1371/journal.pone.0070482
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flowchart of study population.
ICU: intensive care unit; AKI: acute kidney injury; NC: nephrology consultation.
Patients' characteristics according to nephrology consultation status.
| NC | No NC | ||
| Characteristics | (n = 196) | (n = 170) |
|
| Age (years) | 58±18.4 | 56±19.3 | 0.320 |
| Male sex | 125 (63.8) | 93 (54.7) | 0.078 |
| Caucasian | 135 (68.9) | 118 (69.4) | 0.912 |
| Surgical AKI | 42 (21.4) | 44 (25.9) | 0.316 |
| Sepsis | 137 (69.9) | 107 (62.9) | 0.159 |
| CKDFCIII | 61 (31.1) | 32 (18.8) | 0.007 |
| Charlson Comorbidity Index | 2.0 (1.0–4.0) | 2.0 (1.0–3.25) | 0.260 |
| Number of organ system failures | 3.0 (2.0–4.0) | 2.0 (1.0–3.0) | <0.0001 |
| Cardiovascular | 105 (53.6) | 53 (31.2) | <0.0001 |
| Respiratory | 166 (84.7) | 117 (68.8) | <0.0001 |
| Hepatic | 107 (54.6) | 73 (42.9) | 0.026 |
| Neurologic | 110 (56.1) | 74 (43.5) | 0.016 |
| Hematologic | 24 (12.2) | 9 (5.3) | 0.038 |
| SAPS 3 CSA | 69.7±23.8 | 53.5±28.5 | <0.0001 |
| Serum creatinine (mg/dL) | 3.2 (2.3–4.3) | 1.7 (1.3–2.3) | <0.0001 |
| Maximum Serum creatinine (mg/dL) | 4.30 (3.20–5.30) | 2.40 (1.80–3.20) | <0.0001 |
| Blood Urea nitrogen (mg/dL) | 55 (38–77) | 37(23–51) | <0.0001 |
| Diuresis (ml/24 h) | 575 (200–1195) | 1645 (937–2662) | <0.0001 |
| Oliguria (diuresis < 400 ml/24 h) | 75 (38.3) | 17 (10) | <0.0001 |
| Furosemide use (yes/no) | 76 (38.8) | 35 (20.6) | <0.0001 |
| RIFLE Stage | |||
| Risk | 21 (10.7) | 40 (23.5) | 0.001 |
| Injury | 55 (28.1) | 63 (37.1) | 0.066 |
| Failure | 112 (57.1) | 37 (21.8) | <0.0001 |
| Serum bicarbonate (mEq/L) | 15.0 (13–18) | 18 (15–21) | <0.0001 |
| Serum sodium (mEq/L) | 141 (136–146) | 142 (138–145) | 0.314 |
| Serum potassium (mEq/L) | 4.9 (4.0–5.5) | 4.0 (3.5–4.6) | <0.0001 |
| Total Bilirubin (mg/dL) | 0.9 (0.5–2.5) | 0.7 (0.4–1.5) | 0.055 |
| GOT (UI/dL) | 42 (26–99) | 36 (21–60) | 0.015 |
| Pre-AKI ICU LOS (days) | 1.0 (0.0–4.0) | 1.0 (0.0–7.0) | 0.575 |
| Pre-ICU LOS (days) | 4.00 (1.00–14.00) | 3.00 (1.00–9.00) | 0.268 |
| Dialysis | 115 (58.7) | 0 | <0.0001 |
| Time in mechanical ventilation (days) | 12.00 (7.00–19.75) | 10.00 (4.00–24.25) | 0.149 |
| ICU LOS (days) | 16.00 (10.00–25.00) | 17.00 (11.00–39.00) | 0.066 |
| Hospital LOS (days) | 18.50 (11.00–36.00) | 27.50 (14.00–37.00) | <0.0001 |
| Mortality | 154 (78.6) | 90 (55.3) | <0.0001 |
Results are expressed in number (%), mean ± SD or median (25–75 IQR).
Age points were suppressed.
Mortality probability.
After hospital admission.
Dialysis was exclusively performed by nephrologists.
SD, standard deviation; IQR, interquartile range; CKDFCIII, chronic kidney disease functional class III; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America; GOT, aspartate aminotransferase; LOS, length of stay, AKI, acute kidney injury; ICU, intensive care unit.
Variables retained in the propensity score model for nephrology consultation (P<0.05)*.
|
| OR (95% CI) | |
| SAPS 3 CSA | 0.002 | 1.17 (1.06–1.30) |
| SCr (mg/dL) | <0.0001 | 2.34 (1.78–3.08) |
| Diuresis (1000 ml/24 h) | <0.001 | 0.74 (0.58–0.93) |
| Serum potassium (mEq/L) | 0.037 | 1.36 (1.01–1.84) |
| Serum bicarbonate (mEq/L) | 0.037 | 0.53 (0.29–0.96) |
Model performance: area under ROC curve = 0.86 (0.82–0.90); Hosmer-Lemeshow χ2 = 0.29.
Each 10 units.
Each 10 mEq/L.
ROC, receiver operating characteristic; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America; SCr, serum creatinine level; OR, odds ratio; CI, confidence interval.
Patients' characteristics comparing delayed and early nephrology consultation (NC) groups on AKI diagnosis day.
| Delayed NC | Early NC | ||
| Characteristics | (n = 68) | (n = 128) |
|
| Age (years) | 60±18 | 56±18.4 | 0.20 |
| Male sex | 46 (67.6) | 79 (61.7) | 0.41 |
| White | 48 (70.6) | 87 (68.0) | 0.70 |
| Surgical AKI | 23 (33.8) | 19 (14.8) | 0.02 |
| Sepsis | 47 (69.1) | 90 (70.3) | 0.86 |
| CKDFCIII | 22 (32.4) | 39 (30.5) | 0.78 |
| Charlson Comorbidity Index | 5.0 (3.0–6.0) | 4.0 (2.0–6.0) | 0.301 |
| Number of organ system failures | 3.0 (2.0–4.0) | 3.0 (2.0–4.0) | 0.421 |
| Cardiovascular | 59 (86.8) | 103 (80.5) | 0.128 |
| Respiratory | 61 (89.7) | 91 (71.1) | 0.030 |
| Hepatic | 37 (54.4) | 70 (54.7) | 0.971 |
| Neurologic | 36 (52.9) | 64 (50) | 0.695 |
| Hematologic | 5 (7.4) | 19 (14.8) | 0.023 |
| SAPS 3 CSA | 60.7±28.5 | 60.6±26.0 | 0.645 |
| Serum creatinine (mg/dL) | 1.8 (1.5–2.3) | 2.4 (1.8–3.4) | <0.0001 |
| Maximum Serum creatinine (mg/dL) | 4.30 (3.31–5.10) | 4.20 (3.12–5.30) | 0.996 |
| Blood Urea nitrogen (mg/dL) | 33 (23–44) | 41 (27–63) | 0.003 |
| Diuresis (ml/24 h) | 1245 (672–1745) | 625 (250–1257) | <0.0001 |
| Oliguria (diuresis <400 ml/24 h) | 6 (8.8) | 48 (37.5) | <0.0001 |
| Furosemide use (yes/no) | 17 (25) | 37 (28.9) | 0.56 |
| RIFLE Stage | |||
| Risk | 41 (60.3) | 44 (34.4) | <0.0001 |
| Injury | 21 (30.9) | 39 (30.5) | 0.952 |
| Failure | 6 (8.8) | 45 (35.1) | <0.0001 |
| Serum bicarbonate (mEq/L) | 18 (15–21) | 15.7 (13–19) | <0.0001 |
| Serum sodium (mEq/L) | 140 (136–144) | 140 (136–144) | 0.74 |
| Serum potassium (mEq/L) | 4.6 (3.8–5.2) | 4.7 (4.0–5.4) | 0.13 |
| Total bilirubin (mg/dL) | 0.8 (0.5–2.1) | 1.0 (0.5–2.6) | 0.28 |
| GPT (UI/dL) | 22 (15–50) | 31 (17–78) | 0.03 |
| Pre-AKI ICU LOS (days) | 2.0 (0.5–8.0) | 1.0 (0.0–3.0) | <0.001 |
| Pre-ICU LOS (days) | 6.5 (1.0–18.5) | 4.0 (1.0–11.5) | 0.061 |
| Dialysis | 34 (50) | 81 (63.3) | 0.072 |
| Time in mechanical ventilation (days) | 16.5 (11.0–32.0) | 10.0 (6.00–15.0) | <0.0001 |
| ICU LOS (days) | 19.0 (12.5–34.5) | 13.5 (9.00–23.0) | 0.03 |
| Hospital LOS (days) | 20.0 (13.0–36.5) | 18.0 (11.0–36.0) | 0.493 |
| Dialysis dependence | 57 (83.8) | 81 (63.3) | 0.003 |
| Mortality | 62 (91.2) | 92 (71.9) | 0.002 |
Results are expressed in number (%), mean ± SD or median (25–75 IQR).
Age points were suppressed.
Mortality probability.
After hospital admission; SD, standard deviation; IQR, interquartile range; CKDFCIII, chronic kidney disease functional class III; ICU, intensive care unit; CRRT, continuous renal replacement therapy; AKI, acute kidney injury; LOS, length of stay; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America; GPT, alanine aminotransferase.
Variables retained in the propensity score model for delayed nephrology consultation (P<0.05)*.
|
| OR (95% CI) | |
| SCr (mg/dL) | 0.001 | 0.51 (0.35–0.76) |
| Diuresis (1000 ml/24 h) | <0.001 | 2.24 (1.46–3.43) |
| Surgical patients | 0.001 | 3.67 (1.65–8.15) |
| Mechanical ventilation | 0.036 | 2.82 (1.06–744) |
Model performance: area under ROC curve = 0.79 (0.72–0.85); Hosmer-Lemeshow χ2 = 0.48.
ROC, receiver operating characteristic; SCr, serum creatinine level; OR, odds ratio; CI, confidence interval.
Patients characteristics comparing delayed and early Nephrology Consultation (NC) subgroups in both dialyzed and no dialyzed patients on Acute Kidney Injury (AKI) diagnosis day.
| Characteristics | Dialyzed patients (n = 115) | No dialyzed patients (n = 81) | ||||
| Delayed NC (n = 34) | Early NC (n = 81) |
| Delayed NC (n = 34) | Early NC (n = 47) |
| |
| Age (years) | 58±18.4 | 57±18.3 | 0.711 | 57±17.8 | 57±18.9 | 0.807 |
| Male | 73 (63.5) | 51 (63.0) | 0.941 | 25 (73.5) | 26 (55.3) | 0.094 |
| Surgical AKI | 11 (32.4) | 11 (13.6) | 0.02 | 8 (23.5) | 10 (21.3) | 0.810 |
| Sepsis | 82 (71.3) | 55 (67.9) | 0.609 | 23 (67.6) | 32 (68.1) | 0.967 |
| CKDFCIII | 39 (33.9) | 22 (27.2) | 0.315 | 10 (29.4) | 12 (25.5) | 0.698 |
| Charlson Comorbidity Index | 2.0 (1.0–4.0) | 2.0 (1.0–4.0) | 0.499 | 2.0 (1.0–4.0) | 2.0 (1.0–4.0) | 0.953 |
| Number of organ system failures | 3.0 (2.0–4.0) | 2.0 (2.0–4.0) | 0.098 | 3.0 (2.0–4.0) | 3.0 (2.0–3.0) | 0.392 |
| Cardiovascular Failure | 104 (90.4) | 58 (71.6) | 0.001 | 27 (79.4) | 31 (66.0) | 0.185 |
| Respiratory Failure | 31 (91.2) | 59 (72.8) | 0.030 | 30 (88.2) | 32 (68.1) | 0.035 |
| Hepatic | 61 (53.0) | 46 (56.8) | 0.604 | 20 (58.8) | 26 (55.3) | 0.753 |
| Neurologic | 64 (55.7) | 36 (44.4) | 0.122 | 16 (47.1) | 20 (42.6) | 0.687 |
| Hematologic Failure | 3 (8.8) | 12 (14.8) | 0.384 | 2 (5.9) | 7 (14.9) | 0.203 |
| SAPS 3 CSA | 61.2±28.0 | 59.9±24.7 | 0.095 | 60.7±26.0 | 59.3±23.9 | 0.892 |
| Serum creatinine (mg/dL) | 1.9 (1.5–2.5) | 2.5 (1.8–3.6) | <0.0001 | 1.7 (1.4–2.3) | 2.2 (1.7–3.15) | <0.0001 |
| Blood urea nitrogen(mg/dL) | 38 (28–54) | 48 (31–64) | 0.062 | 28 (21–41) | 36 (26–57) | 0.069 |
| Serum bicarbonate (mEq/L) | 16.9 (14.8–19.6) | 14.9 (11.7–17.9) | 0.003 | 16.6 (14.7–18.9) | 15.3 (13.7–16.8) | 0.113 |
| Serum potassium (mEq/L) | 4.7 (3.9–5.5) | 4.5 (4.05–5.15) | 0.284 | 4.4 (3.77–5.1) | 4.7 (4.2–5.2) | 0.283 |
| Diuresis (ml/24 h) | 1050 (710–1500) | 560 (190–1000) | <0.0001 | 1345 (660–1920) | 800 (340–1700) | 0.047 |
| Oliguria (diuresis <400 ml/24 h) | 3 (8.8) | 34 (42.0) | 0.001 | 3 (8.8) | 14 (29.8) | 0.022 |
| Time to star dialysis after ICU admission (days) | 11.0 (7.0–16.0) | 4.00 (2.00–8.00) | <0.0001 | - | - | - |
| Time to start dialysis after AKI diagnosis (days) | 7.0 (5.0–11.0) | 2.0 (1.0–4.0) | <0.0001 | - | - | - |
| Time to NC after AKI diagnosis (days) | 6.00 (4.00–10.00) | 1.00 (0.00–2.00) | <0.0001 | 4.00 (4.00–8.00) | 1.00 (0.00–2.00) | <0.0001 |
| Time to start dialysis after NC (days) | 1.0 (0.0–2.0) | 1.0 (0.0–3.0) | 0.053 | - | - | - |
| Pre-AKI ICU LOS (days) | 1.0 (0.0–6.0) | 0.0 (0.0–3.0) | 0.090 | 3.0 (1.0–11.0) | 1.0 (0.0–3.5) | 0.002 |
| Pre-ICU LOS (days) | 7.0 (1.0–16.0) | 3.0 (1.0–8.0) | 0.074 | 5.5 (1.0–19.0) | 5.0 (1.0–16.5) | 0.516 |
| Time in mechanical ventilation (days) | 17.0 (11.0–30.0) | 11.0 (7.00–16.0) | <0.0001 | 15.5 (10.0–35.0) | 8.0 (3.50–14.0) | <0.0001 |
| ICU LOS (days) | 18.5 (11.0–32.0) | 13.0 (9.00–22.0) | 0.024 | 19.5 (14.0–38.0) | 16.0 (9.00–23.5) | 0.073 |
| Hospital LOS (days) | 18.5 (11.0–33.0) | 16.0 (10.0–36.0) | 0.391 | 22.5 (14.0–48.0) | 22.0 (12.5–34.5) | 0.550 |
| Dialysis dependence at hospital discharge | 57 (83.8) | 81 (63.3) | 0.003 | - | - | - |
| Mortality | 34 (100) | 63 (77.8) | 0.003 | 28 (82.4) | 29 (61.7) | 0.045 |
Results are expressed in number (%), mean ± SD or median (25–75 IQR).
Age points were suppressed.
Mortality probability.
After hospital admission.
CKDFCIII, chronic kidney disease functional class III; ICU, intensive care unit; AKI, acute kidney injury; LOS, length of stay; SAPS, simplified acute physiology score; CSA, customized equation for countries from Central and South America.